This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3522
Title
Decreased, Pregnenolone levels leads to Decreased, Progesterone levels
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
Taxonomic Applicability
Term | Scientific Term | Evidence | Link |
---|---|---|---|
mammals | mammals | High | NCBI |
Sex Applicability
Sex | Evidence |
---|---|
Mixed | High |
Life Stage Applicability
Term | Evidence |
---|---|
All life stages | High |
Key Event Relationship Description
This key event relationship describes decreased levels of pregnenolone that causes a decrease in progesterone levels.
Pregnenolone is the precursor to all steroid hormones and is the direct precursor to progesterone. Progesterone is synthesized from the conversion of pregnenolone by 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) (Bremer & Miller, 2014; Kamrath et al., 2014). Therefore, a decrease in the levels of pregnenolone can negatively impact the levels of progesterone through a lack of substrate for the enzymatic reaction. A decrease in pregnenolone can happen through multiple mechanisms: pregnolone can be converted to 17-OH pregnenolone, it can be sulfated to pregnenolone-S (Bremer & Miller, 2014; V et al., 2018), and the upstream reactions leading to pregnenolone synthesis may be affected. Interference with any of these processes can lead to decreased pregnenolone levels, which again may decrease progesterone levels.
Evidence Collection Strategy
The KER describes a generally recognized and understood process, i.e. canonical knowledge. The aim of the literature search was therefore to identify review articles and book chapter that summarise the canonical knowledge. PubMed was searched using key words related to steroidogenesis.
Evidence Supporting this KER
Biological Plausibility
It is well established that the synthesis and presence of pregnenolone is necessary for progesterone synthesis.
The conversion of pregnenolone to progesterone occurs in several different tissues and in a species specific way by the 3-beta-HSD enzyme (Q et al., 2019). It takes place in the ovaries where pregnenolone is converted to progesterone from granulosa cells into the corpus luteum (Bremer & Miller, 2014). This conversion also occurs in the adrenal cortex and in Leydig cells primarly in rats and mice to produce androgens (Bremer & Miller, 2014; S et al., 2021; WL, 2017).
Empirical Evidence
Since pregnenolone is a precursor to all steroid hormones, inhibiting its production should have an impact on all downstream hormone levels.
This was shown in a study using a specific inhibitor of CYP11A1, the enzyme responsible for the conversion of cholesterol to pregnenolone. The small molecule, named ODM-208, successfully inhibited CYP11A1 which resulted in drastic decrease in pregnenolone levels in H295R cells at 100 nM. At this same concentration, progesterone and other downstream hormones, decreased production to below detection level (Karimaa et al., 2022).
Using a short-term diabetes model in Wistar rats, another study demonstrated the link between the decrease of pregnenolone in the kidneys with reduced progesterone levels. By administering streptozotocin (STZ), the rats presented symptoms of early diabetes. When inspecting protein levels, a clear decrease in CYP11A1 expression was observed in kidney tissues. This was reflected in the decrease of renal pregnenolone and subsequently, a decrease in progesterone levels. However, expression of 3-beta-HSD was not evaluated and therefore can not be excluded as playing a part in the progesterone decrease (Pagotto et al., 2021).
Cocaine exposure prenatally in rats also impacted the levels of both maternal and fetal pregnenolone and progesterone. The exposure to cocaine was executed during the third trimester twice daily (15 mg/kg/day). It had no impact on placental 3-beta-HSD1 expression but decreased expression of the mRNA and protein CYP11A (Wu et al., 2012).
Association between decreased pregnenolone and progesterone levels is observed in different species and life stages. For example, aged female rats and male rats have decreased levels of pregnenolone and progesterone compared to younger female rats (Gaignard et al., 2015). Another link between the two is seen in healthy neonatal foals, where at birth they contain high levels of plasma steroid hormones which then decrease after 48 hours. Pregnenolone and progesterone decrease drastically within 24h after birth (Aleman et al., 2019).
Uncertainties and Inconsistencies
Pregnenolone is converted to 17-OH pregnenolone preferentially in humans (Kamrath et al., 2014).
Progesterone itself can reduce pregnenolone (Yuan et al., 2019).
Progesterone levels also depends on the activity of the enzyme 3-beta-HSD (Q et al., 2019).
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
Taxonomic applicability
Both pregnenolone and progesterone synthesis and regulation is conserved in mammals (Baker, 2011; DM et al., 2017).
Life stage applicability
This KER is applicable to all life stages as both hormones are essential (Baker, 2011; Bremer & Miller, 2014; DM et al., 2017).
Sex applicability
Pregnenolone and progesterone are expressed and important in males and females (Baker, 2011; Bremer & Miller, 2014).
References
Aleman, M., McCue, P. M., Chigerwe, M., & Madigan, J. E. (2019). Plasma concentrations of steroid precursors, steroids, neuroactive steroids, and neurosteroids in healthy neonatal foals from birth to 7 days of age. Journal of Veterinary Internal Medicine, 33(5), 2286–2293. https://doi.org/10.1111/jvim.15618
Baker, M. E. (2011). Origin and diversification of steroids: Co-evolution of enzymes and nuclear receptors. Molecular and Cellular Endocrinology, 334(1–2), 14–20. https://doi.org/10.1016/j.mce.2010.07.013
Bremer, A. A., & Miller, W. L. (2014). Regulation of Steroidogenesis. In Cellular Endocrinology in Health and Disease (pp. 207–227). Elsevier. https://doi.org/10.1016/B978-0-12-408134-5.00013-5
DM, S., AH, Z., LN, T., K, M., & V, S. (2017). A brief history of the search for the protein(s) involved in the acute regulation of steroidogenesis. Molecular and Cellular Endocrinology, 441, 7–16. https://doi.org/10.1016/j.mce.2016.07.036
Gaignard, P., Savouroux, S., Liere, P., Pianos, A., Thérond, P., Schumacher, M., Slama, A., & Guennoun, R. (2015). Effect of Sex Differences on Brain Mitochondrial Function and Its Suppression by Ovariectomy and in Aged Mice. Endocrinology, 156(8), 2893–2904. https://doi.org/10.1210/en.2014-1913
Kamrath, C., Wudy, S. A., & Krone, N. (2014). Steroid Biochemistry (pp. 41–52). https://doi.org/10.1159/000363612
Karimaa, M., Riikonen, R., Kettunen, H., Taavitsainen, P., Ramela, M., Chrusciel, M., Karlsson, S., Rummakko, P., Simola, O., Wohlfahrt, G., Hakulinen, P., Vuorela, A., Joensuu, H., Utriainen, T., Fizazi, K., & Oksala, R. (2022). First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. Molecular Cancer Therapeutics, 21(12), 1765–1776. https://doi.org/10.1158/1535-7163.MCT-22-0115
Pagotto, M. A., Roldán, M. L., Molinas, S. M., Raices, T., Pisani, G. B., Pignataro, O. P., & Monasterolo, L. A. (2021). Impairment of renal steroidogenesis at the onset of diabetes. Molecular and Cellular Endocrinology, 524, 111170. https://doi.org/10.1016/j.mce.2021.111170
Q, Z., P, P., X, C., Y, W., S, Z., J, M., X, L., & RS, G. (2019). Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors. Toxicology, 425, 152253. https://doi.org/10.1016/j.tox.2019.152253
S, C.-P., T, L., P, L., C, D.-L., A, D., PA, F., & S, M.-G. (2021). Six Decades of Research on Human Fetal Gonadal Steroids. International Journal of Molecular Sciences, 22(13). https://doi.org/10.3390/ijms22136681
V, S., DM, S., & BJ, C. (2018). Current knowledge on the acute regulation of steroidogenesis. Biology of Reproduction, 99(1), 13–26. https://doi.org/10.1093/biolre/ioy102
WL, M. (2017). Steroidogenesis: Unanswered Questions. Trends in Endocrinology and Metabolism: TEM, 28(11), 771–793. https://doi.org/10.1016/j.tem.2017.09.002
Wu, L., Yan, J., Qu, S. C., Feng, Y. Q., & Jiang, X. L. (2012). Abnormal regulation for progesterone production in placenta with prenatal cocaine exposure in rats. Placenta, 33(12), 977–981. https://doi.org/10.1016/j.placenta.2012.10.001
Yuan, X., Yang, C., Wang, X., Zhang, L., Gao, X., & Shi, Z. (2019). Progesterone maintains the status of granulosa cells and slows follicle development partly through PGRMC1. Journal of Cellular Physiology, 234(1), 709–720. https://doi.org/10.1002/jcp.26869